Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**BAZ1A-AS1** is a long non-coding RNA (lncRNA) transcribed antisense to the BAZ1A (Bromodomain adjacent to zinc finger domain 1A) gene, whose product is involved in chromatin assembly and remodeling[1][5]. Antisense RNAs such as BAZ1A-AS1 often regulate the expression of their corresponding sense genes (such as BAZ1A) either through transcriptional interference, chromatin modification, or direct RNA-RNA interactions. There are no published studies or functional characterizations in the current literature explicitly detailing the molecular or disease roles of BAZ1A-AS1 specifically. Generally, antisense RNAs can modulate sense gene expression, participate in chromatin structure regulation, and may contribute to gene silencing or activation depending on context[6]. As of current knowledge, BAZ1A-AS1 is not known to be a direct therapeutic target, nor have any drugs been developed to modulate its expression or function. **Key clarifications**: - There is no evidence that BAZ1A-AS1 is a protein, receptor, or drug target; it is a lncRNA whose functions are general to the category of antisense RNAs[6]. - The BAZ1A protein itself, not the antisense RNA, is involved in chromatin remodeling and has been implicated in transcriptional regulation, DNA repair, and other nuclear processes[1][4][5]. - This antisense RNA may regulate BAZ1A expression or chromatin state but is not directly actionable as a therapeutic target given current data.
none known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BAZ1A antisense RNA 1 (BAZ1A-AS1).